The incorporation of a hydroxyethylene dipeptide isostere at the P2/P3 sites of renin inhibitors maintains in vitro activity while enhancing stability.
No takes yet. Share an insight, caveat, or question.
May inform renin inhibitor design; leaves open in vivo efficacy and clinical translation.
Kempf et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: